Study: COVID-19 Pandemic Is Slowing Down Lung Cancer Treatment For 60% Of Patients

Video Credit: Wochit News
Published on September 16, 2020 - Duration: 00:34s

Study: COVID-19 Pandemic Is Slowing Down Lung Cancer Treatment For 60% Of Patients

The COVID-19 pandemic has disrupted work, school, and social life around the world.

And that's not all.

According to UPI, a new study shows the novel coronavirus pandemic has caused delays in treatment for nearly 60% of lung cancer patients.

For some patients, the data showed treatment delays incurred between March 2 and May 30 lasted a month or more.

At a major health system in Canada, Just under 40% of lung cancer patients saw delays or discontinuation of "palliative chemotherapy.


You are here

Related videos from verified sources

Kidney Damage Caused By COVID-19 00:33
Video credit: Wochit - Published on September 22, 2020 

KU Medical Center conducting multiple COVID-19 studies 02:16
Video credit: 41 Action News - Published on September 22, 2020 

CDC: COVID-19 Puts Pregnant Women, Babies At Risk Of Serious Complications 00:46
Video credit: Wochit Tech - Published on September 17, 2020 

You might like